John Peter Zajicek

Summary

Country: UK

Publications

  1. pmc Effect of dronabinol on progression in progressive multiple sclerosis (CUPID): a randomised, placebo-controlled trial
    John Zajicek
    Peninsula Clinical Trials Unit, Plymouth University Peninsula Schools of Medicine and Dentistry, Plymouth, UK Electronic address
    Lancet Neurol 12:857-65. 2013
  2. doi request reprint Multiple sclerosis and extract of cannabis: results of the MUSEC trial
    John Peter Zajicek
    Clinical Neurology Research Group, Peninsula College of Medicine and Dentistry, University of Plymouth, Derriford, UK
    J Neurol Neurosurg Psychiatry 83:1125-32. 2012

Detail Information

Publications2

  1. pmc Effect of dronabinol on progression in progressive multiple sclerosis (CUPID): a randomised, placebo-controlled trial
    John Zajicek
    Peninsula Clinical Trials Unit, Plymouth University Peninsula Schools of Medicine and Dentistry, Plymouth, UK Electronic address
    Lancet Neurol 12:857-65. 2013
    ..Laboratory evidence has shown that cannabinoids might have a neuroprotective action. We investigated whether oral dronabinol (Δ(9)-tetrahydrocannabinol) might slow the course of progressive multiple sclerosis...
  2. doi request reprint Multiple sclerosis and extract of cannabis: results of the MUSEC trial
    John Peter Zajicek
    Clinical Neurology Research Group, Peninsula College of Medicine and Dentistry, University of Plymouth, Derriford, UK
    J Neurol Neurosurg Psychiatry 83:1125-32. 2012
    ..Here we report the results of the Multiple Sclerosis and Extract of Cannabis (MUSEC) study that aimed to substantiate the patient based findings of previous studies...